Sinovac covid-19 vaccine

Sinovac covid-19 vaccine aka CoronaVac, is an inactivated virus covid-19 vaccine developed by the Chinese company Sinovac Biotech.

News

 * 12 Jul 2021, Politico.eu, China’s vaccine makers ink deal for up to 550M doses with Covax, Both vaccines have received emergency use listing from the World Health Organization. However, the Sinovac jab has faced difficulties in recent weeks, with several Southeast Asian countries expressing concern about its efficacy. Most recently, Thailand announced it would be giving the Oxford/AstraZeneca vaccine as a second dose to those who had a first dose of Sinovac, in an attempt to increase protection.
 * 12 Jun 2021, TheEconomist.com, A town in Brazil has vaccinated nearly everyone against covid-19, Its success shows what could have been in the rest of the country
 * 01 Jun 2021, Politico.eu, WHO lists China’s Sinovac vaccine for emergency use, The jab showed an efficacy of 51 percent against symptomatic disease and 100 percent efficacy in preventing severe covid-19. The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) said Tuesday that the Sinovac vaccine showed an efficacy of 51 percent against symptomatic disease and 100 percent efficacy in preventing severe covid-19 and hospitalization.
 * 04 May 2021, Politico.eu, EU regulator starts review of China’s Sinovac vaccine, The EMA didn’t provide a time frame for its final decision, but it said the process should ‘take less time than normal.’
 * 17 Apr 2021, TheEconomist.com, China presses Hong Kongers to accept a Chinese vaccine, Many would prefer a better one, or distrust the whole process. Most public-health experts have concerns about the way China’s jab has been promoted in Hong Kong but are scared to speak publicly about it, say three such individuals. They worry that discussing the efficacy of a Chinese vaccine will hurt their careers, or even be deemed a violation of the city’s new security law, which bans any act that seriously “undermines” the work of the local or central governments.
 * 15 Apr 2021, TheEconomist.com, In clinical and real world trials, China’s Sinovac underperforms, The vaccine has already been exported to 19 countries. Despite the apparently poor results in stopping infections, the Sinovac vaccine, like its competitors, appears to offer remarkably good protection against severe disease and death. In the Brazil phase-three trials, nearly 4% of the unvaccinated participants who were infected got severely ill; among the vaccinated, none did.
 * 31 Mar 2021, (fr) 7sur7.be, Les vaccins chinois “sûrs et efficaces”, pour l'OMS, Les vaccins des laboratoires chinois Sinopharm et Sinovac ont montré qu’ils étaient sûrs et efficaces contre la Covid-19, mais des données supplémentaires sont nécessaires, ont indiqué mercredi les experts de l’OMS.